COMORBIDITY OF AUTOIMMUNE THYROIDITIS AND PARKINSON’S DISEASE

Authors

DOI:

https://doi.org/10.21856/j-PEP.2024.2.02

Keywords:

Parkinson’s disease, autoimmune thyroiditis, antithyroid antibodies, thyroid hormones

Abstract

The review of the results of clinical research revealed a significant connection of thyropathology with the increased risk of Parkinson’s disease (PD). The topical issue now is to specify the influence of thyroid hormones and autoimmune disorders among PD patients.

The purpose of the work is to establish the frequency of autoimmune thyroid pathology among PD patients.

Materials and methods. Ultrasound examination of thyroid gland (TG) was performed, thyroid status (thyroid-stimulating hormone (TSH) and free thyroxine (T4) levels) as well as the indicators of antithyroid antibodies to thyroid peroxidase and thyroglobulin (TPO, TG) and stimulating antibodies to TSH receptors (TSHRAb) were evaluated among 45 patients aged 50-70 years old with PD of various degrees of severity as the indicators of the state of humoral antithyroid immunity.

Results. The presence of thyroid gland autoimmune pathology was revealed among 31 PD patients (68.8%). The largest number of patients with autoimmune thyroiditis (AITD) had a tremulous form of PD (91.3%). The patients with akinetic-rigid-tremorous form (84.62%) were in the second place while the patients with an akinetic-rigid form (11.11%) were in the third place. According to hormonal status, euthyroidism was present in 25.8%of cases, hypothyroidism in 54.8%, hyperthyroidism in 19.35%. According to the thyroid gland ultrasound examination, in all the cases there was structure heterogeneity and capsular thickening, which are the signs of AITD.

Conclusions. Patients with autoimmune thyroid dysfunction have an increased risk of developing Parkinson’s disease. The presence of antithyroid antibodies is associated with neurodegenerative disorders, including Parkinson’s disease.

References

1. Marino BLB, de Souza LR, Sousa KPA, et al. Mini Rev Med Chem 2020;20(9): 754-767. http://doi.org/10.2174/1389557519666191104110908.

De Virgilio A, Greco A, Fabbrini G, et al. Autoimmun Rev 2016;15(10): 1005-1011. http://doi.org/10.1016/j.autrev.2016.07.022.

Karaban' IM, Karasevych HB. Zhurn Nevrol im. BM. Man'kovs'kogo 2020;8(3/4): 63-72.

Moskovko SP, et al. НейроNEWS 2017;1: 48-50.

Karaban' IM, Bezrukov VV, Golovchenko JuI, Cymbaljuk VI. НейроNEWS 2017;10(93): 50-68.

Starovojtova GO, et al. Mizhnar Nevrol Zhurn 2016;3: 161-162.

Váradi C. Biology (Basel) 2020;9(5): 103. http://doi.org/10.3390/biology9050103.

Chairta PP, Hadjisavvas A, Georgiou AN, et al. Genes (Basel) 2021;12(8): 1278. http://doi.org/10.3390/genes12081278

Anwar A, Saleem S, Akhtar A, et al. Cureus 2019;11(8): e5409. http://doi.org/10.7759/cureus.5409

Braun D, Schweizer U. Vitam Horm 2018;106: 19-44. http://doi.org/10.1016/bs.vh.2017.04.005.

Tan Y, Gao L, Yin Q, et al. Int J Neurosci 2021;131(4): 346-356. http://doi.org/10.1080/00207454.2020.1744595.

Kim JH, Lee HS, Ahn JH, et al. J Parkinson's Dis 2021;11: 211-220. http://doi.org/10.3233/JPD-202265

Lee E-H, Kim S-M, Kim C-H, et al. Sci Rep 2019;9: 13659. http://doi.org/10.1038/s41598-019-49876-6.

Mohammadi S, Dolatshahi M, Rahmani F. J Endocrinol Invest 2021;44: 1-13. http://doi.org/10.1007/s40618-020-01314-5.

Charoenngam N, Rittiphairoj T, Ponvilawan B, Prasongdee K. Front Endocrinol (Lausanne) 2022;13: 863281. http://doi.org/10.3389/fendo.2022.863281

Shydlovs'kyj VO, Pan'kiv VI, Sydorchuk LP, et al. Avtoimunnyj tyreoi'dyt u novij real'nosti (intrygujuchy hvoroba cherez stolittja pislja pershogo opysu), Ternopil', 2021: 278 p.

Stepien BK, Huttner WB. Front Endocrinol 2019;10. http://doi.org/10.3389/fendo.2019.00209

Figueroa PBS, Ferreira AFF, Britto LR, et al. Metab Brain Dis 2021;36: 1523-1543. http://doi.org/10.1007/s11011-021-00760-1

Feldman AZ, Shrestha RT, Hennessey JV. Endocrinol Metab Clin North Am 2013;42: 453-476. http://doi.org/10.1016/j.ecl.2013.05.005.

Joy Mathew C, Jose MT, Elshaikh AO, et al. Cureus 2020;12: e10603. http://doi.org/10.7759/cureus.10603

Chen SF, Yang YC, Hsu CY, Shen YC. Parkinsonism Related Disord 2020;74: 28-32. http://doi.org/10.1016/j.parkreldis.2020.04.001

Lin SR, Chen SF, Yang YC, et al. Endocr Connect 2021;10: 13-20. http://doi.org/10.1530/EC-20-0554 16.

Ehm G, Kim HJ, Jeon B. Tremor Other Hyperkinetic Mov 2017;7: 505. http://doi.org/10.5334/tohm.364

Мatheoud D, Sugiura A, Bellemare-Pelletier A, et al. Cell 2016;166(2): 314-327. http://doi.org/10.1016/j.cell.2016.05.039.

Cho YY, Kim B, Shin DW, et al. Brain Commun 2022;4(1). http://doi.org/10.1093/braincomms/fcac014

Хu J, Zhao C, Liu Y, et al. Clin Exp Immunol 2022;208(3): 372-379. http://doi.org/10.1093/cei/uxac044

Napolitano F, D'Angelo L, de Girolamo P, et al. Neurosci 2018;384: 419-428. http://doi.org/10.1016/j.neuroscience.2018.05.027.

Chaker L, Razvi S, Bensenor IM, et al. Nat Rev Dis Primers 2022;8: 30. http://doi.org/10.1038/s41572-022-00357-7

Hoehn MM, Yahr MD. Neurology 1967;17: 427-442.

Schneider SA, Tschaidse L, Reisch N. Mov Dis Clin Pract 2023;10: 360-368. http://doi.org/10.1002/mdc3.13656

Bayram T, Bayram D, Yüksel GA, Tireli H. Haydarpasa Numune Med J 2023;63(3): 252-257. http://doi.org/10.14744/hnhj.2022.68889

Published

2024-06-15

How to Cite

Goncharova, O., & Zavalna, O. (2024). COMORBIDITY OF AUTOIMMUNE THYROIDITIS AND PARKINSON’S DISEASE. Problems of Endocrine Pathology, 81(2), 14–20. https://doi.org/10.21856/j-PEP.2024.2.02

Issue

Section

CLINICAL ENDOCRINOLOGY

Most read articles by the same author(s)

1 2 > >> 

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.